Kyntra Bio Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Kyntra Bio Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- KYNB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000921299
Board of directors
-
Aoife Brennan · DirectorSince 2023
-
Benjamin Cravatt · DirectorSince 2023
-
Enrique A. Conterno · Director · Chief Executive OfficerSince 2023
-
Gerald Lema · DirectorSince 2023
-
James A. Schoeneck · DirectorSince 2023
-
Jeffrey L. Edwards · DirectorSince 2023
-
Jeffrey William Henderson · DirectorSince 2023
-
Maykin Ho · DirectorSince 2023
-
Michael Kauffman · DirectorSince 2025
-
Suzanne Blaug · DirectorSince 2023
-
Thane Wettig · Director · CEOSince 2024
Chief executives
Thane Wettig
· CEO
Dates unknown
Enrique A. Conterno
· Chief Executive Officer
Dates unknown
Board connections
7 of this board's directors also sit on 15 other boards.
- via Michael Kauffman
- via Maykin Ho
- via Benjamin Cravatt
- via Jeffrey William Henderson
- via Jeffrey L. Edwards
- via Maykin Ho
- via James A. Schoeneck
- via Aoife Brennan
- via James A. Schoeneck
- via Jeffrey William Henderson
- via Jeffrey L. Edwards
- via Maykin Ho
- via Jeffrey William Henderson
- via Michael Kauffman
- via Aoife Brennan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $53,602
- 3 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 6, 2026 | DeLucia David Officer (Chief Financial Officer) | Shares withheld for tax | −22 | $8.55 | $188 |
| Sep 6, 2026 | Thane Wettig Director, Officer (CEO) | Shares withheld for tax | −209 | $8.55 | $1,787 |
| Jun 6, 2026 | Thane Wettig Director, Officer (CEO) | Shares withheld for tax | −198 | $6.71 | $1,329 |
| Jun 6, 2026 | DeLucia David Officer (Chief Financial Officer) | Shares withheld for tax | −52 | $6.71 | $349 |
| May 14, 2026 | Thane Wettig Director, Officer (CEO) | Open-market purchase | −2,800 | $7.09 | $19,852 |
| Mar 6, 2026 | Thane Wettig Director, Officer (CEO) | Shares withheld for tax | −277 | $6.84 | $1,895 |
| Mar 6, 2026 | DeLucia David Officer (Chief Financial Officer) | Shares withheld for tax | −60 | $6.84 | $410 |
| Dec 6, 2025 | DeLucia David Officer (Chief Financial Officer) | Shares withheld for tax | −52 | $8.42 | $438 |
| Dec 6, 2025 | Thane Wettig Director, Officer (CEO) | Shares withheld for tax | −259 | $8.42 | $2,181 |
| Nov 17, 2025 | Thane Wettig Director, Officer (CEO) | Open-market purchase | +2,700 | $9.10 | $24,570 |
| Nov 13, 2025 | Thane Wettig Director, Officer (CEO) | Open-market purchase | +1,000 | $9.18 | $9,180 |
| Sep 6, 2025 | DeLucia David Officer (Chief Financial Officer) | Shares withheld for tax | −53 | $12.10 | $641 |
| Sep 6, 2025 | Thane Wettig Director, Officer (CEO) | Shares withheld for tax | −248 | $12.10 | $3,001 |
| Jun 30, 2025 | James A. Schoeneck Director | Open-market purchase | +23,567 | $5.07 | $119,485 |
| Jun 6, 2025 | DeLucia David Officer (Chief Financial Officer) | Shares withheld for tax | −51 | $7.83 | $399 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.